Research Article

Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma

Figure 1

Survival outcomes in patients with sarcomatoid metastatic renal cell carcinoma (SmRCC). (a) Overall survival in SmRCC. (b) Progression-free survival of treated SmRCC. Overall survival stratified by MSKCC (c) and Heng risk criteria (d), extent of sarcomatoid component (e), and IMP3 staining (f).
(a) Overall survival
(b) Progression-free survival
(c) MSKCC criteria
(d) Heng criteria
(e) Sarcomatoid component
(f) IMP3